Bybee Clinton — insider trades

Stock trades Bybee Clinton reported on SEC Form 4 at BOLD Boundless Bio, Inc., LYEL Lyell Immunopharma, Inc., NMRA Neumora Therapeutics, Inc..

• Jul 1, 2026: sold 16,000 shares of BOLD Boundless Bio, Inc. ($39.8K)
• Mar 6, 2026: bought 488,090 shares of LYEL Lyell Immunopharma, Inc. ($12.5M)
• Oct 27, 2025: bought 1,915,700 shares of NMRA Neumora Therapeutics, Inc. ($5.00M)